In
When:
December 14, 2020 @ 9:00 am – 12:00 pm
2020-12-14T09:00:00-08:00
2020-12-14T12:00:00-08:00
Where:
Online Webinar
Contact:
CASAT Training
778-784-6265

Live Webinar – Management of Benzodiazepine Disorder

Learning Objectives
At the end of this webinar, participants should be able to:

  1. Distinguish between benzodiazepine dependence and benzodiazepine use disorder
  2. Appropriately use diagnostic criteria for benzodiazepine use disorders
  3. Be familiar with the pharmacology of benzodiazepines
  4. Understand risk factors for developing benzodiazepine use disorder
  5. Describe benzodiazepine withdrawal
  6. List common treatment options including the Ashton method for tapering
  7. Understand how other substances, including opioid, sinteract with benzodiazepines
  8. Respond to common liability concerns with appropriate documentation
  9. Understand the risks associated with MAT Treatment and benzodiazepines

Presenter: Candy Stockton-Joreteg, MD, FASAM

Continuing Education Units: 3 CEUs

Workshops are approved by the following professional associations for continuing education units:

National

  • International Certification & Reciprocity Consortium (IC&RC)
  • National Association of Alcohol & Drug Abuse Counselors (NAADAC)
  • National Board for Certified Counselors (NBCC)

Nevada

  • Nevada State Board of Examiners for Alcohol, Drug & Gambling Counselors
  • Nevada State Board of Nursing
  • State of Nevada Board of Examiners for Marriage and Family Therapists & Clinical Professional Counselors
  • State of Nevada Board of Examiners for Social Workers

Cost: $45.00 (with CEU certificate); Free for Information Only

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search

Pacific Southwest Prevention Technology Transfer Center‎Webinar: Adverse Childhood Experiences and Chronic Stress: Building Resilience During and After COVID-19